What is Pfizer's paxlovid — revenues:?

Pfizer (PFE) reported paxlovid — revenues: of $186.00M in Q1 2026.

How has Pfizer's paxlovid — revenues: changed year-over-year?

Pfizer's paxlovid — revenues: decreased by 62.1% year-over-year, from $491.00M to $186.00M.

Paxlovid — Revenues:

Pfizer Paxlovid — Revenues: decreased by 84.8% to $186.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 62.1%, from $491.00M to $186.00M.

Analysis

StatementSegment

First reportedQ3 2022

Last reportedQ1 2026May 5, 2026

Rolls up toTotal Revenue

Metric ID: pfe_segment_paxlovid_revenues

Historical Data

11 periods

	Q3 '22	Q1 '23	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	$7.51B	$4.07B	$143.00M	$202.00M	$2.04B	$251.00M	$2.70B	$491.00M	$427.00M	$1.23B	$186.00M
QoQ Change	—	-45.8%	-96.5%	+41.3%	+907.4%	-87.7%	+976.9%	-81.8%	-13.0%	+186.9%	-84.8%
YoY Change	—	—	—	-97.3%	-50.0%	+75.5%	>999%	-75.9%	+70.1%	-54.7%	-62.1%

Range$143.00M – $7.51B

CAGR-77.2%

Avg YoY Growth+130.5%

Median YoY Growth-52.3%

Frequently Asked Questions

What is Pfizer's paxlovid — revenues:?: Pfizer (PFE) reported paxlovid — revenues: of $186.00M in Q1 2026.
How has Pfizer's paxlovid — revenues: changed year-over-year?: Pfizer's paxlovid — revenues: decreased by 62.1% year-over-year, from $491.00M to $186.00M.